66984635.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

66984635.Pdf THE ENCYCLOPEDIA OF SKIN AND SKIN DISORDERS THE ENCYCLOPEDIA OF SKIN AND SKIN DISORDERS Third Edition Carol Turkington Jeffrey S. Dover, M.D. Medical Illustrations Birck Cox To the memory of Dottie Kennedy, for her unfailing support h The Encyclopedia of Skin and Skin Disorders, Third Edition Copyright © 1996, 2002, 2007 by Carol Turkington All rights reserved. No part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage or retrieval systems, without permission in writing from the publisher. For information contact: Facts On File, Inc. An imprint of Infobase Publishing 132 West 31st Street New York NY 10001 Library of Congress Cataloging-in-Publication Data Turkington, Carol. The encyclopedia of skin and skin disorders / Carol Turkington, Jeffrey S. Dover ; medical illustrations, Birck Cox.— 3rd ed. p. cm. Includes index. ISBN 0-8160-6403-2 1. Dermatology—Encyclopedias. 2. Skin—Diseases—Encyclopedias. 3. Skin—Encyclopedias. I. Dover, Jeffrey S. II. Title. RL41.T87 2006 616.5003—dc22 2005057402 Facts On File books are available at special discounts when purchased in bulk quantities for businesses, associations, institutions, or sales promotions. Please call our Special Sales Department in New York at (212) 967-8800 or (800) 322-8755. You can fi nd Facts On File on the World Wide Web at http://www.factsonfi le.com Text and cover design by Cathy Rincon Printed in the United States of America VB FOF 10 9 8 7 6 5 4 3 2 1 This book is printed on acid-free paper. CONTENTS Foreword vii Introduction xv Acknowledgments xvii Entries A–Z 1 Appendixes 405 Glossary 425 Bibliography 429 Index 439 FOREWORD The future of skin disease prevention and treat- longed, lasting months to years after a 20-week ment is bright. Better understanding of the course, a result unable to be achieved by any genetics of disease will help researchers to dis- other acne medication. Some side effects from cover the causes of many common ailments, isotretinoin are seen in most of its users, but usu- and continued technological developments ally resolve one to three weeks after treatment. will ensure even better treatments. The major These include dryness of the skin, mouth, and advances in dermatology over the last decade membranes, as well as chapped lips and patches include revolutionary anti-acne medication and of eczema. Fragile skin and susceptibility to sun- drugs that combat immune diseases; advances burn are frequently reported. Dry eyes, nose- in skin cancer awareness; new lasers and light bleeds, hair shedding, muscle and joint pains are sources engineered to improve skin appearance, common. Bone and blood lipid abnormalities can texture, and tone; and the development of Botu- also occur. Recently, depression and suicide have linum Exotoxin A and fi llers to decrease facial been reported among patients taking isotretinoin, lines and creases. although in the past some studies had shown an The single most notable event in the fi eld improvement in emotional well-being. Whether of acne treatment was the crucial discovery of isotretinoin plays a role in depression is unclear. isotretinoin in 1979 for the treatment of severe A recent large study failed to show an increased acne. This drug’s approval in 1982 revolution- risk of depression in isotretinoin users compared ized therapy; today the drug remains the treat- with other acne patients. ment of choice for resistant severe nodular cystic One of the most signifi cant problems with acne, although it is under increasing regulatory isotretinoin is its risk of the development of serious scrutiny because of uncommon but potentially birth defects in the infants of women who conceive signifi cant side effects of birth defects and depres- while on treatment. This requires that no woman sion. Isotretinoin belongs to a class of compounds being put on the drug become pregnant under any called retinoids, which are vitamin A derivatives. circumstances. To prevent pregnancy in women It is the only truly effective treatment against undergoing isotretinoin treatment, contraceptive severe cystic acne and has been shown to pre- counseling prior to starting treatment is essential, vent scarring, a disastrous result of acne. Isotreti- and strict monitoring of women of childbearing noin affects the sebaceous gland, suppressing age during the treatment course is performed. Two sebum production to preteen levels and causes negative pregnancy tests are required prior to the a decrease in the levels of bacteria responsible start of therapy, and monthly testing is compul- for acne. It also promotes shedding of skin cells. sory for sexually active females during treatment. Isotretinoin can reduce acne by 90 percent or Guidelines suggest that pregnancy is safe one more within three months. Its effects are pro- month after stopping the drug. vii viii Foreword Immunologic Drugs in an effort to reduce the risk of overuse of these highly effective treatments. IFN-a Interferon alpha is an agent that can modulate the immune system used in the treat- ment of cancers of the blood, immune diseases, Systemic Biologics and in the treatment of genital warts. A large Recent advances in technology have led to a pro- number of new clinical uses of interferon are being liferation of new strategies for treating diseases developed. The recent introduction of interferon with agents that can be designed to act specifi cally alpha into current therapies for malignant mela- on the immune system and may prove to be safer noma is notable. As immune control mechanisms than traditional therapies. Biologic agents are seem to be important in the behavior of mela- proteins that can be extracted from animal tissue noma, biological agents have been the subject of or synthesized in the laboratory. These medica- many studies involving treatment. Results sug- tions are divided into two categories: monoclonal gest that interferon alpha may be benefi cial, most antibodies and fusion receptor proteins. Mono- clearly in preventing recurrence but also perhaps clonal antibodies are usually derived from mouse in overall survival. Further studies are needed in antibodies and engineered to be better tolerated order to determine its benefi t, and it cannot yet by human beings. Fusion receptor proteins are be recommended as a standard therapy in high- human antibodies that are constructed in the risk malignant melanoma, although it remains a laboratory from components that are not normally promising mode of treatment. combined by the human body. Over the last decade, immune mediated diseases Topical Immunomodulators Imiquimod cream such as Crohn’s disease and rheumatoid arthri- induces the release of interferons and has been tis have been successfully treated with biologic approved in the United States for the treatment of agents. In 2003 the Food and Drug Administra- genital warts, as well as actinic keratoses (pre–skin tion (FDA) approved alefacept, a fusion receptor cancers). Research also shows that it is effective protein, for the treatment of moderate to severe in the treatment of superfi cial spreading basal psoriasis. This drug reduces the number and func- cell carcinoma, a slowly growing local type of tion of specifi c white blood cells important in skin cancer; studies are currently under way that infl ammatory reactions of the skin. Efulizumab, examine its effectiveness in the treatment of pre- an example of a monoclonal antibody, similarly cancerous skin growths due to the sun, nongenital decreases the ability of white blood cells to par- warts, molluscum, and alopecia areata. ticipate in infl ammation. Etanercept, a fusion Tacrolimus ointment (Protopic) and pimecro- receptor protein, binds the infl ammatory molecule limus cream (Elidel) are powerful topical anti- tumor necrosis factor-alpha (TNF-a). The reduc- infl ammatory agents approved for the treatment tion of TNF-a leads to the improvement of many of eczema. The greatest development in the treat- infl ammatory disorders of the skin. ment of eczema since the discovery of steroids in These three drugs have been approved for the the 1950s, its major advantage over topical cor- treatment of moderate to severe psoriasis. Other ticosteroids, the mainstay of treatment of atopic biologics, such as adalimumab and infl iximab, dermatitis treatment, is that it is not associated have been used to successfully treat psoriasis, with the development of the side effects such as though they are not approved by the FDA for this thinning of the skin and the formation of promi- use. Many of these biologics have demonstrated nent blood vessels and stretch marks. These new the ability to improve other infl ammatory dis- agents are particularly useful at sites where the eases of the skin such as hidradenitis suppurativa skin is more delicate, such as the face, groin, and and pyoderma gangrenosum. These agents and underarms. They should be used only on the their effectiveness in treating other diseases will affected area until it clears and then treatment remain an area of intense investigation in the should be discontinued until the next outbreak future. Foreword ix Systemic biologics are an exciting new option Advantages of pulse therapy include effective- in the management of some skin diseases. These ness with a similar or decreased frequency of side drugs are signifi cantly more expensive than tradi- effects, economy, and convenience. tional systemic medications such as methotrexate and acitretin, though they may prove to be safer UVB narrow band for chronic use. Long-term evaluation of the cost effectiveness and safety of these new medications Among the most effective therapies for psoria- will determine their ultimate role in dermatology. sis is ultraviolet light phototherapy at 290–320 nm wavelength, and more recently narrowband UVB at 311 nanometers wavelength, which has Antifungals been shown to be more effective than broadband Today most cases of nail fungus can be cured using UVB.
Recommended publications
  • Chloracne: from Clinic to Research
    DERMATOLOGICA SINICA 30 (2012) 2e6 Contents lists available at SciVerse ScienceDirect Dermatologica Sinica journal homepage: http://www.derm-sinica.com REVIEW ARTICLE Chloracne: From clinic to research Qiang Ju 1, Kuochia Yang 2, Christos C. Zouboulis 3, Johannes Ring 4, Wenchieh Chen 4,* 1 Department of Dermatology, Shanghai Skin Disease and STD Hospital, Shanghai, People’s Republic of China 2 Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan 3 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany 4 Department of Dermatology and Allergy, Technische Universität München, Munich, Germany article info abstract Article history: Chloracne is the most sensitive and specific marker for a possible dioxin (2,3,7,8-tetrachlorodibenzo-p- Received: Oct 31, 2011 dioxin) intoxication. It is clinically characterized by multiple acneiform comedone-like cystic eruptions Revised: Nov 9, 2011 mainly involving face in the malar, temporal, mandibular, auricular/retroauricular regions, and the Accepted: Nov 9, 2011 genitalia, often occurring in age groups not typical for acne vulgaris. Histopathology is essential for adefinite diagnosis, which exhibits atrophy or absence of sebaceous glands as well as infundibular Keywords: dilatation or cystic formation of hair follicles, hyperplasia of epidermis, and hyperpigmentation of aryl hydrocarbon receptor stratum corneum. The appearance of chloracne and its clinical severity does not correlate with the blood chloracne “ ” 2,3,7,8-tetrachlorodibenzo-p-dioxin levels of dioxins. Pathogenesis of chloracne remains largely unclear. An aryl hydrocarbon receptor - polyhalogenated aromatic hydrocarbons mediated signaling pathway affecting the multipotent stem cells in the pilosebaceous units is probably sebaceous gland the major molecular mechanism inducing chloracne.
    [Show full text]
  • Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D
    Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department of Dermatology and Cutaneous Surgery What Determines Skin Color? What Determines Skin Color? No significant difference in the number of melanocytes between the races 2000 epidermal melanocytes/mm2 on head and forearm 1000 epidermal melanocytes/mm2 on the rest of the body differences present at birth Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff,K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192-220, New York, NY: McGraw Hill Melanosomes in Black and White Skin Black White Szabo G, Gerald AB, Pathak MA, Fitzpatrick TB. Nature1969;222:1081-1082 Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192- 220, New York, NY: McGraw Hill Role of Melanin-Advantages Melanin absorbs and scatters energy from UV and visible light to protect epidermal cells from UV damage Disadvantages Inflammation or injury to the skin is almost immediately accompanied by alteration in pigmentation Hyperpigmentation Hypopigmentation Dyschromias Post-Inflammatory hyperpigmentation Acne Melasma Lichen Planus Pigmentosus Progressive Macular Hypomelanosis
    [Show full text]
  • Senile Lentigo – Cosmetic Or Medical Issue of the Elderly Population
    Coll. Antropol. 34 (2010) Suppl. 2: 85–88 Original scientific paper Senile Lentigo – Cosmetic or Medical Issue of the Elderly Population Mirna [itum1, Vedrana Bulat1, Marija Buljan1, Zvonimir Puljiz2, V. [itum3 and @eljana Bolan~a1 1 Department of Dermatology and Venereology, University Hospital »Sestre Milosrdnice«, Zagreb, Croatia 2 Department of General Surgery, University Hospital »Sestre milosrdnice«, Zagreb, Croatia 3 Department of General Practice, Split, Croatia ABSTRACT Senile lentigo or age spots are hyperpigmented macules of skin that occur in irregular shapes, appearing most com- monly in the sun- exposed areas of the skin such as on the face and back of the hands. Senile lentigo is a common compo- nent of photoaged skin and is seen most commonly after the age of 50. There are many disscusions on whether senile lentigo represents a melanoma precursor, namely lentigo maligna melanoma and, if there is a need for a regular follow up in cases of multiple lesions. Clinical opservations sometimes report that in the location of the newly diagnosed mela- noma, such lesion preexsisted. On contrary, some authors believe that senile lentigo represents a precursor of seborrheic keratosis, which does not require a serious medical treatment. However, the opservation of the possible association of se- nile lentigo with the melanoma development makes us cautious in the assessment of this lesion. Histologically, there are elongated rete ridges with increased melanin at the tips, and the number of melanocytes is not increased. The dermato- scopic features are also distinctive. If the lesion becomes inflammed it may evolve into benign lichenoid keratosis. Cryo- therapy and laser treatment are common therapeutic approaches.
    [Show full text]
  • Forever Young: the Social Transformation of Aging in America Since 1900
    Forever Young: The Social Transformation of Aging in America Since 1900 The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Fallon, Cara Kiernan. 2018. Forever Young: The Social Transformation of Aging in America Since 1900. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:41121250 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Forever Young: The Social Transformation of Aging in America Since 1900 A dissertation presented by Cara Kiernan Fallon to The Department of History of Science in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of History of Science Harvard University Cambridge, Massachusetts August 2018 © 2018 Cara Kiernan Fallon All rights reserved. Allan M. Brandt Cara Kiernan Fallon Forever Young: The Social Transformation of Aging in America Since 1900 Abstract Between 1900 and 2000, life expectancy in the United States increased by three decades—from 47 to 77—a greater increase in one century than in the entire previous history of humankind. With it, the population over sixty-five increased from four to twelve percent of the United States population, and those over eighty-five became the fastest-growing demographic group. While growing old has become increasingly common, the processes of aging have not become welcomed or accepted.
    [Show full text]
  • (CD-P-PH/PHO) Report Classification/Justifica
    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
    [Show full text]
  • Erythema Ab Igne Erythema Ab Igne
    gyöngyösi quark 10/18/13 8:48 Page 1 BÔRGYÓGYÁSZATI ÉS VENEROLÓGIAI SZEMLE • 2013 • 89. ÉVF. 5. 127–131. • DOI 10.7188/bvsz.2013.89.5.3 Erythema ab igne Erythema ab igne GYÖNGYÖSSY ORSOLYA DR., DARÓCZY JUDIT DR. Egyesített Szent István és Szent László Kórház – Rendelôintézet, Bôrgyógyászati Szakrendelô és Lymphoedema Rehabilitációs osztály, Budapest ÖSSZEFOGLALÁS SUMMARY Az erythema ab igne jelentése „bôrpír a tûztôl”. A bôr- Erythema ab igne means „redness from fire”. tünetek az ismétlôdô, 43-47 C fokos hôhatásra alakulnak Symptoms resulting from prolonged or repeated exposure ki. Régebben kályha, sugárzó hô okozta a tüneteket, újab- to moderate heat. The heat source used to be stove, and ban laptop, ágymelegítô hatása is bizonyított. A klinikai other infrared radiation, nowadays the role of laptop tüneteket retikuláris pigmentáció, petechiák, hólyagok, computer, hot blanket and many others are proved. The atypikus sebek jellemzik. Három észlelt esetben lehetôség clinical symptomes are reticular hyperpigmentation, volt az eltérô klinikai megjelenés bemutatására. A bôr petechia, blisters, aypical ulcers. Three different cases mikrocirkulációs zavara lézer-Doppler módszerrel igazol- show the variant clinical manifestation. Pathologic ható. A szerzôk elsôként vetik fel, hogy a bôrtünet kialaku- dermal microcirculation was verified with Laser Doppler lása a bôr kapillárisainak a hôhatásra adott kóros reak- examination. The authors first raised the relationship ciójával függhet össze. A ritkán diagnosztizált kórkép between abnormal capillary respond to heat and the onset felismerése azért fontos, mert az ismétlôdô vagy folyama- of skin symptoms. It is important to be familiar with this tos hám irritáció következtében elszarusodó laphámrák rarely diagnosed disease because the chronic epidermal keletkezhet és Merkel sejtes carcinomát is leírtak.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Pityriasis Alba Revisited: Perspectives on an Enigmatic Disorder of Childhood
    Pediatric ddermatologyermatology Series Editor: Camila K. Janniger, MD Pityriasis Alba Revisited: Perspectives on an Enigmatic Disorder of Childhood Yuri T. Jadotte, MD; Camila K. Janniger, MD Pityriasis alba (PA) is a localized hypopigmented 80 years ago.2 Mainly seen in the pediatric popula- disorder of childhood with many existing clinical tion, it primarily affects the head and neck region, variants. It is more often detected in individuals with the face being the most commonly involved with a darker complexion but may occur in indi- site.1-3 Pityriasis alba is present in individuals with viduals of all skin types. Atopy, xerosis, and min- all skin types, though it is more noticeable in those with eral deficiencies are potential risk factors. Sun a darker complexion.1,3 This condition also is known exposure exacerbates the contrast between nor- as furfuraceous impetigo, erythema streptogenes, mal and lesional skin, making lesions more visible and pityriasis streptogenes.1 The term pityriasis alba and patients more likely to seek medical atten- remains accurate and appropriate given the etiologic tion. Poor cutaneous hydration appears to be a elusiveness of the disorder. common theme for most riskCUTIS factors and may help elucidate the pathogenesis of this disorder. The Epidemiology end result of this mechanism is inappropriate mel- Pityriasis alba primarily affects preadolescent children anosis manifesting as hypopigmentation. It must aged 3 to 16 years,4 with onset typically occurring be differentiated from other disorders of hypopig- between 6 and 12 years of age.5 Most patients are mentation, such as pityriasis versicolor alba, vitiligo, younger than 15 years,3 with up to 90% aged 6 to nevus depigmentosus, and nevus anemicus.
    [Show full text]
  • Pattern of Skin Tumours in Kashmir Valley of North India: a Hospital Based Clinicopathological Study
    International Journal of Information Research and Review, February 2015 International Journal of Information Research and Review Vol. 2, Issue, 02, pp. 376-381 February, 2015 Research Article PATTERN OF SKIN TUMOURS IN KASHMIR VALLEY OF NORTH INDIA: A HOSPITAL BASED CLINICOPATHOLOGICAL STUDY 1,*Peerzada Sajad, 2Iffat Hassan, 3Ruby Reshi, 4Atif Khan and 5Waseem Qureshi 1MBBS, MD Senior Resident, Postgraduate Department of Dermatology, GMC Srinagar, India 2Associate Professor and Head Postgraduate Department of Dermatology, STD and Leprosy GMC Srinagar, 3Associate professor and Head Postgraduate Department of Pathology GMC Srinagar, 4Scholar, PostgraduateIndia Department of Dermatology, STD and Leprosy GMC Srinagar, 5Chief physician and Registrar Academics, Government Medical College Srinagar, India India India ARTICLE INFO ABSTRACT Article History: Background: Earlier studies have shown that the incidence of all varieties of skin cancers is lower Received 27th November, 2014 among Indians due to the protective effects of melanin.However the pattern of skin cancers in kashmir Received in revised form valley is different from the rest of India due to the presence of Kangri cancer. 20th December, 2014 Objective: Our aim was to assess the distribution pattern of skin tumours among ethnickashmiri Accepted 30th January, 2015 population presenting to a tertiary care hospital in Kashmir and comparison of clinical diagnosis with st Published online 28 February, 2015 histopathological confirmation. Methods: This study was a prospective hospital based which was conducted over a one year period Keywords: on patients’ attending the outpatient department of Dermatology of our hospital and presenting with Non-Melanoma Skin Cancers, clinical features suspicious of benign or malignant skin tumours .All the relevant investigations Benign, including a skin biopsy were done in every individual patient to determine the type of tumour.
    [Show full text]
  • Mask-Induced Acne Flare During Coronavirus Disease-19. What Is It and How to Manage It?
    Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2020 Oct 31; 8(T1):411-415. https://doi.org/10.3889/oamjms.2020.5388 eISSN: 1857-9655 Category: T1 - Thematic Issue “Coronavirus Disease (COVID-19)” Section: Narrative Review Article MASKNE: Mask-Induced Acne Flare During Coronavirus Disease-19. What is it and How to Manage it? Laura Pauline Kosasih Department of Dermatology, Cardiff University, Cardiff, Wales, United Kingdom Abstract Edited by: Mirko Spiroski The coronavirus disease (COVID)-19 is a global pandemic caused by severe acute respiratory syndrome (SARS)- Citation: Kosasih LP. MASKNE: Mask Induced Acne Flare During Coronavirus Disease-19. What is it and How to CoV-2. Due to the rapid spread of the disease, several measures have been proposed to mitigate its transmission, Manage it? Open Access Maced J Med Sci. 2020 Oct 31; including wearing a mask in certain circumstances. This new proposition leads to some novel skin adverse effects; 8(T1):411-415. one of them is acne flare. This particular outbreak has significantly affected people’s quality of life. In this minireview, https://doi.org/10.3889/oamjms.2020.5388 Keywords: Acne; MASKNE (Mask Acne); a brief current knowledge of SARS-CoV-2 and its related-acne-flare, or popularly called as mask-acne (MASKNE), Coronavirus Disease-19 are discussed. This review aims to provide some information that may be helpful in opting for the most suitable *Correspondence: Laura Pauline Kosasih, Department of Dermatology, Cardiff
    [Show full text]
  • Understanding the Molecular Mechanism of Phytoconstituents As
    Saudi Journal of Medical and Pharmaceutical Sciences Abbreviated Key Title: Saudi J Med Pharm Sci ISSN 2413-4929 (Print) |ISSN 2413-4910 (Online) Scholars Middle East Publishers, Dubai, United Arab Emirates Journal homepage: https://saudijournals.com Review Article Understanding the Molecular Mechanism of Phytoconstituents as Tyrosinase Inhibitors for Treatment of Hyperpigmentation Lata Kothapalli1*, Pooja Sawant2, AshaThomas1, Ravindra Wavhale1, Komal Bhosale2 1Faculty, Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Gaikwad Haraibhau Vinayan Rd, Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra 411018, India 2Research Scholar, Department of Pharmaceutical Quality Assurance, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Gaikwad Haraibhau Vinayan Rd, Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra 411018, India DOI: 10.36348/sjmps.2021.v07i02.010 | Received: 08.01.2021 | Accepted: 20.01.2021 | Published: 27.02.2021 *Corresponding author: Lata Kothapalli Abstract Skin Pigmentation is a phenomenon in which the accumulation of melanin occurs due to various factors and leads to skin tanning and other skin disorders. Now a day’s human beings are more conscious about quality of life and appearance. With this fascination towards various skin whitening or glowing agents is gaining more adherences. While synthetic chemicals approved as skin whitening agents have got the due recognition in market, the possible adverse effects on sensitive skin creates a question regarding their use. The natural plant extracts available as tyrosinase inhibitors are mostly phenolic entities. In this review the inhibitory effect of phenolic compound and flavonoids on tyrosinase enzyme using molecular simulations is studied. The insilico study of flavonoids helps to predict the mechanism of inhibition as well as identification of potential natural tyrosinase inhibitors.
    [Show full text]
  • Consumers' Policy by Malena Boome a Thesis Submitted in Partial
    Cosmetics: Consumers’ Choice; Consumers’ Policy by Malena Boome A Thesis Submitted in partial fulfillment of the requirements for the degree Master of Environmental Studies The Evergreen State College June 2018 ©2018 by Malena Boome. All rights reserved. This Thesis for the Master of Environmental Studies Degree by Malena Boome has been approved for The Evergreen State College by ________________________ Edward A. Whitesell, Ph. D. Member of the Faculty ________________________ Date ABSTRACT Cosmetics: Consumers’ Choice; Consumers’ Policy Malena Boome Human exposure to toxins happens in a variety of ways in people’s daily lives. Most of these toxins are known; however, one source of toxic chemical exposure may be coming from a lesser-known place, from cosmetics. Cosmetics policy in the United States under the authority of the U.S. Food and Drug Administration is often referred to as much more relaxed than in other similarly developed countries such as those in the European Union. This thesis researches whether or not current cosmetics policy in the United States matches the opinions and perceptions of the consumers the policy is in place to protect. As of now, there is information coming from professional parties such as politicians, cosmetic companies, and scientists that inform the current cosmetics policy in the United States. This research concludes that consumer’s opinions and perceptions do not align with current cosmetics policy in the United States. Natural cosmetics were seen as a viable alternative to conventional cosmetics in the United States, and this research explores barriers that may be disconnecting consumers from purchasing these products. This research conducted an online survey that asked questions regarding opinions on current policies, as well as natural cosmetics and policy suggestions that have been made by researchers and cosmetic safety advocacy groups.
    [Show full text]